
Rei Tsang Shiao
Examiner (ID: 13461)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1626, 1628, 1629, 1691 |
| Total Applications | 3000 |
| Issued Applications | 2172 |
| Pending Applications | 215 |
| Abandoned Applications | 676 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 654929
[patent_doc_number] => 07109222
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-19
[patent_title] => 'Compounds that modulate PPAR activity and methods of preparation'
[patent_app_type] => utility
[patent_app_number] => 11/025271
[patent_app_country] => US
[patent_app_date] => 2004-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20641
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/109/07109222.pdf
[firstpage_image] =>[orig_patent_app_number] => 11025271
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/025271 | Compounds that modulate PPAR activity and methods of preparation | Dec 23, 2004 | Issued |
Array
(
[id] => 6939859
[patent_doc_number] => 20050113422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Compounds that modulate PPAR activity and methods of preparation'
[patent_app_type] => utility
[patent_app_number] => 11/020391
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20619
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113422.pdf
[firstpage_image] =>[orig_patent_app_number] => 11020391
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/020391 | Compounds that modulate PPAR activity and methods of preparation | Dec 21, 2004 | Abandoned |
Array
(
[id] => 5011428
[patent_doc_number] => 20070281907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Kinase Inhibitor Phosphonate Conjugates'
[patent_app_type] => utility
[patent_app_number] => 10/583683
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37026
[patent_no_of_claims] => 67
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20070281907.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583683
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583683 | Kinase Inhibitor Phosphonate Conjugates | Dec 21, 2004 | Abandoned |
Array
(
[id] => 263937
[patent_doc_number] => 07569703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-04
[patent_title] => 'Fluorinating agent and method for producing fluorine-containing compound using the same'
[patent_app_type] => utility
[patent_app_number] => 10/583608
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8482
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/569/07569703.pdf
[firstpage_image] =>[orig_patent_app_number] => 10583608
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/583608 | Fluorinating agent and method for producing fluorine-containing compound using the same | Dec 20, 2004 | Issued |
Array
(
[id] => 289192
[patent_doc_number] => 07547807
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-16
[patent_title] => 'Method for producing phosphonium salts'
[patent_app_type] => utility
[patent_app_number] => 10/582912
[patent_app_country] => US
[patent_app_date] => 2004-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4949
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/547/07547807.pdf
[firstpage_image] =>[orig_patent_app_number] => 10582912
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/582912 | Method for producing phosphonium salts | Dec 13, 2004 | Issued |
Array
(
[id] => 123295
[patent_doc_number] => 07705047
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-27
[patent_title] => 'Amidoacetonitrile derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/581463
[patent_app_country] => US
[patent_app_date] => 2004-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13114
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/705/07705047.pdf
[firstpage_image] =>[orig_patent_app_number] => 10581463
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/581463 | Amidoacetonitrile derivatives | Dec 8, 2004 | Issued |
Array
(
[id] => 928639
[patent_doc_number] => 07314949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-01
[patent_title] => 'Trans-1,2-cyclohexane bis(urea-urethane) compounds'
[patent_app_type] => utility
[patent_app_number] => 11/004682
[patent_app_country] => US
[patent_app_date] => 2004-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17906
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/314/07314949.pdf
[firstpage_image] =>[orig_patent_app_number] => 11004682
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/004682 | Trans-1,2-cyclohexane bis(urea-urethane) compounds | Dec 3, 2004 | Issued |
Array
(
[id] => 925824
[patent_doc_number] => 07317122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-08
[patent_title] => 'Curable trans-1,2-cyclohexane bis(urea-urethane) compounds'
[patent_app_type] => utility
[patent_app_number] => 11/004761
[patent_app_country] => US
[patent_app_date] => 2004-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14826
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/317/07317122.pdf
[firstpage_image] =>[orig_patent_app_number] => 11004761
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/004761 | Curable trans-1,2-cyclohexane bis(urea-urethane) compounds | Dec 3, 2004 | Issued |
Array
(
[id] => 7051306
[patent_doc_number] => 20050187193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Alpha-substituted beta-aminoethyl phosphonate derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/001378
[patent_app_country] => US
[patent_app_date] => 2004-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21219
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187193.pdf
[firstpage_image] =>[orig_patent_app_number] => 11001378
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/001378 | Alpha-substituted beta-aminoethyl phosphonate derivatives | Nov 30, 2004 | Abandoned |
Array
(
[id] => 7075200
[patent_doc_number] => 20050148468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Recording material and recording sheet'
[patent_app_type] => utility
[patent_app_number] => 10/999630
[patent_app_country] => US
[patent_app_date] => 2004-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11911
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148468.pdf
[firstpage_image] =>[orig_patent_app_number] => 10999630
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/999630 | Recording material and recording sheet | Nov 29, 2004 | Issued |
Array
(
[id] => 217304
[patent_doc_number] => 07612214
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-03
[patent_title] => 'Organic amine salts of glutamic acid derivatives and their application'
[patent_app_type] => utility
[patent_app_number] => 10/992795
[patent_app_country] => US
[patent_app_date] => 2004-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 8949
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/612/07612214.pdf
[firstpage_image] =>[orig_patent_app_number] => 10992795
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/992795 | Organic amine salts of glutamic acid derivatives and their application | Nov 21, 2004 | Issued |
Array
(
[id] => 892294
[patent_doc_number] => 07345060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity'
[patent_app_type] => utility
[patent_app_number] => 10/992927
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51965
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/345/07345060.pdf
[firstpage_image] =>[orig_patent_app_number] => 10992927
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/992927 | Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity | Nov 18, 2004 | Issued |
Array
(
[id] => 5603039
[patent_doc_number] => 20060293384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Isethionyl nitrates and compounds thereof'
[patent_app_type] => utility
[patent_app_number] => 10/993469
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7952
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20060293384.pdf
[firstpage_image] =>[orig_patent_app_number] => 10993469
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/993469 | Isethionyl nitrates and compounds thereof | Nov 18, 2004 | Abandoned |
Array
(
[id] => 5265551
[patent_doc_number] => 20090118236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-07
[patent_title] => 'Novel Phosphorus-Containing Thyromimetics'
[patent_app_type] => utility
[patent_app_number] => 10/580134
[patent_app_country] => US
[patent_app_date] => 2004-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 183847
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20090118236.pdf
[firstpage_image] =>[orig_patent_app_number] => 10580134
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/580134 | Phosphorus-containing thyromimetics | Nov 18, 2004 | Issued |
Array
(
[id] => 7256084
[patent_doc_number] => 20050143316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Hepatitis C virus inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/992566
[patent_app_country] => US
[patent_app_date] => 2004-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25816
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143316.pdf
[firstpage_image] =>[orig_patent_app_number] => 10992566
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/992566 | Hepatitis C virus inhibitors | Nov 17, 2004 | Issued |
Array
(
[id] => 7110605
[patent_doc_number] => 20050208060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Vaccine composition'
[patent_app_type] => utility
[patent_app_number] => 10/989154
[patent_app_country] => US
[patent_app_date] => 2004-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5815
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208060.pdf
[firstpage_image] =>[orig_patent_app_number] => 10989154
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/989154 | Vaccine composition | Nov 14, 2004 | Issued |
Array
(
[id] => 6906177
[patent_doc_number] => 20050101572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-12
[patent_title] => 'Novel carnitine conjugates as dual prodrugs and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/987839
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6551
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20050101572.pdf
[firstpage_image] =>[orig_patent_app_number] => 10987839
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/987839 | Carnitine conjugates as dual prodrugs and uses thereof | Nov 11, 2004 | Issued |
Array
(
[id] => 6959484
[patent_doc_number] => 20050215548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-29
[patent_title] => 'Bisarylsulfonamide compounds and their use in cancer therapy'
[patent_app_type] => utility
[patent_app_number] => 10/988388
[patent_app_country] => US
[patent_app_date] => 2004-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 33615
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20050215548.pdf
[firstpage_image] =>[orig_patent_app_number] => 10988388
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/988388 | Bisarylsulfonamide compounds and their use in cancer therapy | Nov 11, 2004 | Abandoned |
Array
(
[id] => 7048390
[patent_doc_number] => 20050184277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Method for preparing arylphosphonite antioxidant'
[patent_app_type] => utility
[patent_app_number] => 10/983620
[patent_app_country] => US
[patent_app_date] => 2004-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2198
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20050184277.pdf
[firstpage_image] =>[orig_patent_app_number] => 10983620
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/983620 | Method for preparing arylphosphonite antioxidant | Nov 8, 2004 | Issued |
Array
(
[id] => 7105155
[patent_doc_number] => 20050107341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-19
[patent_title] => 'Phosphinic acids'
[patent_app_type] => utility
[patent_app_number] => 10/983363
[patent_app_country] => US
[patent_app_date] => 2004-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9967
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20050107341.pdf
[firstpage_image] =>[orig_patent_app_number] => 10983363
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/983363 | Phosphinic acids | Nov 7, 2004 | Issued |